1.49
price up icon1.36%   0.02
after-market Handel nachbörslich: 1.55 0.06 +4.03%
loading

Finanzdaten der Pliant Therapeutics Inc-Aktie (PLRX)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2025-06-30 2025-03-31 2024-09-30 2024-06-30 2024-03-31
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
-
- - - -
Operating Expenses
22.64%
45.59
58.94 62.01 60.64 52.39
Operating Income/Loss
22.64%
-45.59
-58.94 -62.01 -60.64 -52.39
Income/Loss From Continuing Operations Before Tax
22.91%
-43.30
-56.17 -57.76 -55.85 -46.95
Income Tax Expense/Benefit
-
- - - -
Income/Loss From Continuing Operations After Tax
22.91%
-43.30
-56.17 -57.76 -55.85 -46.95
Net Income/Loss
22.91%
-43.30
-56.17 -57.76 -55.85 -46.95
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
0.27%
61.39
61.22 60.73 60.38 60.18
Diluted Average Shares
0.27%
61.39
61.22 60.73 60.38 60.18
Basic Earnings Per Share
22.83%
-0.71
-0.92 -0.95 -0.92 -0.78
Diluted Earnings Per Share
22.83%
-0.71
-0.92 -0.95 -0.92 -0.78
Common Stock Dividends
-
- - - -
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$84.73
price up icon 1.11%
$22.93
price up icon 7.40%
$32.68
price up icon 2.73%
$102.30
price up icon 0.24%
$163.94
price up icon 0.99%
biotechnology ONC
$327.03
price up icon 2.16%
Kapitalisierung:     |  Volumen (24h):